These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32072906)

  • 21. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine Learning Models Combined with Virtual Screening and Molecular Docking to Predict Human Topoisomerase I Inhibitors.
    Li B; Kang X; Zhao D; Zou Y; Huang X; Wang J; Zhang C
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31167344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of Novel HIV-1 Integrase Inhibitors Using QSAR-Based Virtual Screening of the NCI Open Database.
    Ko GM; Garg R; Bailey BA; Kumar S
    Curr Comput Aided Drug Des; 2016; 12(2):135-53. PubMed ID: 27076270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The power metric: a new statistically robust enrichment-type metric for virtual screening applications with early recovery capability.
    Lopes JCD; Dos Santos FM; Martins-José A; Augustyns K; De Winter H
    J Cheminform; 2017; 9():7. PubMed ID: 28203291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly predictive hologram QSAR models of nitrile-containing cruzain inhibitors.
    Silva DG; Rocha JR; Sartori GR; Montanari CA
    J Biomol Struct Dyn; 2017 Nov; 35(15):3232-3249. PubMed ID: 27809673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of the negative-positive ratio and screening database size on the performance of machine learning-based virtual screening.
    Kurczab R; Bojarski AJ
    PLoS One; 2017; 12(4):e0175410. PubMed ID: 28384344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome prediction of intracranial aneurysm treatment by flow diverters using machine learning.
    Paliwal N; Jaiswal P; Tutino VM; Shallwani H; Davies JM; Siddiqui AH; Rai R; Meng H
    Neurosurg Focus; 2018 Nov; 45(5):E7. PubMed ID: 30453461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacophore- based virtual screening, 3D- QSAR, molecular docking approach for identification of potential dipeptidyl peptidase IV inhibitors.
    Shah BM; Modi P; Trivedi P
    J Biomol Struct Dyn; 2021 Apr; 39(6):2021-2043. PubMed ID: 32242496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and rigorous validation of antimalarial predictive models using machine learning approaches.
    Danishuddin ; Madhukar G; Malik MZ; Subbarao N
    SAR QSAR Environ Res; 2019 Aug; 30(8):543-560. PubMed ID: 31328578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GA(M)E-QSAR: a novel, fully automatic genetic-algorithm-(meta)-ensembles approach for binary classification in ligand-based drug design.
    Pérez-Castillo Y; Lazar C; Taminau J; Froeyen M; Cabrera-Pérez MÁ; Nowé A
    J Chem Inf Model; 2012 Sep; 52(9):2366-86. PubMed ID: 22856471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting post-stroke pneumonia using deep neural network approaches.
    Ge Y; Wang Q; Wang L; Wu H; Peng C; Wang J; Xu Y; Xiong G; Zhang Y; Yi Y
    Int J Med Inform; 2019 Dec; 132():103986. PubMed ID: 31629312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Machine learning to predict 30-day quality-adjusted survival in critically ill patients with cancer.
    Santos HGD; Zampieri FG; Normilio-Silva K; Silva GTD; Lima ACP; Cavalcanti AB; Chiavegatto Filho ADP
    J Crit Care; 2020 Feb; 55():73-78. PubMed ID: 31715534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
    Melo-Filho CC; Braga RC; Muratov EN; Franco CH; Moraes CB; Freitas-Junior LH; Andrade CH
    Eur J Med Chem; 2019 Feb; 163():649-659. PubMed ID: 30562700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probing the Hypothesis of SAR Continuity Restoration by the Removal of Activity Cliffs Generators in QSAR.
    Cruz-Monteagudo M; Medina-Franco JL; Perera-Sardiña Y; Borges F; Tejera E; Paz-Y-Miño C; Pérez-Castillo Y; Sánchez-Rodríguez A; Contreras-Posada Z; Cordeiro MN
    Curr Pharm Des; 2016; 22(33):5043-5056. PubMed ID: 27157417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method.
    Wei Y; Li W; Du T; Hong Z; Lin J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LIT-PCBA: An Unbiased Data Set for Machine Learning and Virtual Screening.
    Tran-Nguyen VK; Jacquemard C; Rognan D
    J Chem Inf Model; 2020 Sep; 60(9):4263-4273. PubMed ID: 32282202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile-QSAR 2.0: Kinase Virtual Screening Accuracy Comparable to Four-Concentration IC
    Martin EJ; Polyakov VR; Tian L; Perez RC
    J Chem Inf Model; 2017 Aug; 57(8):2077-2088. PubMed ID: 28651433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rethinking the threshold for an abnormal capillary blood lead screening test.
    Sargent JD; Dalton MA
    Arch Pediatr Adolesc Med; 1996 Oct; 150(10):1084-8. PubMed ID: 8859143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.